Search Results

There are 14768 results for: content related to: Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy

  1. You have free access to this content
    Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

    British Journal of Haematology

    Volume 164, Issue 1, January 2014, Pages: 39–52, Graham P. Collins, Anne N. Parker, Christopher Pocock, Irfan Kayani, Anna Sureda, Tim Illidge, Kirit Ardeshna, David C. Linch and Karl S. Peggs, on behalf of the British Committee for Standards in Haematology, and the British Society of Blood and Marrow Transplantation

    Version of Record online : 1 OCT 2013, DOI: 10.1111/bjh.12582

  2. You have free access to this content
    Guidelines on the management of AL amyloidosis

    British Journal of Haematology

    Volume 168, Issue 2, January 2015, Pages: 186–206, Ashutosh D. Wechalekar, Julian D. Gillmore, Jenny Bird, Jamie Cavenagh, Stephen Hawkins, Majid Kazmi, Helen J. Lachmann, Philip N. Hawkins, Guy Pratt and on behalf ofthe BCSH Committee

    Version of Record online : 9 OCT 2014, DOI: 10.1111/bjh.13155

  3. You have free access to this content
    Guidelines for the investigation and management of mantle cell lymphoma

    British Journal of Haematology

    Volume 159, Issue 4, November 2012, Pages: 405–426, P. McKay, M. Leach, R. Jackson, G. Cook and S. Rule

    Version of Record online : 21 SEP 2012, DOI: 10.1111/bjh.12046

  4. Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial

    British Journal of Haematology

    Volume 173, Issue 5, June 2016, Pages: 731–741, Elias K. Mai, Axel Benner, Uta Bertsch, Peter Brossart, Annette Hänel, Volker Kunzmann, Ralph Naumann, Kai Neben, Gerlinde Egerer, Anthony D. Ho, Jens Hillengass, Marc S. Raab, Andreas Neubauer, Astrid Peyn, Yon-Dschun Ko, Norma Peter, Christof Scheid and Hartmut Goldschmidt

    Version of Record online : 17 MAR 2016, DOI: 10.1111/bjh.13994

  5. You have free access to this content
    Guidelines for the management of diffuse large B-cell lymphoma

    British Journal of Haematology

    Volume 174, Issue 1, July 2016, Pages: 43–56, Sridhar Chaganti, Tim Illidge, Sally Barrington, Pam Mckay, Kim Linton, Kate Cwynarski, Andrew McMillan, Andy Davies, Simon Stern, Karl Peggs and on behalf of the British Committee for Standards in Haematology

    Version of Record online : 16 MAY 2016, DOI: 10.1111/bjh.14136

  6. High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma

    British Journal of Haematology

    Volume 171, Issue 5, December 2015, Pages: 788–797, Ryan D. Cassaday, Philip A. Stevenson, Theodore A. Gooley, Thomas R. Chauncey, John M. Pagel, Joseph Rajendran, Brian G. Till, Mary Philip, Johnnie J. Orozco, William I. Bensinger, Leona A. Holmberg, Andrei R. Shustov, Damian J. Green, Stephen D. Smith, Edward N. Libby, David G. Maloney, Oliver W. Press and Ajay K. Gopal

    Version of Record online : 12 OCT 2015, DOI: 10.1111/bjh.13773

  7. The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma

    British Journal of Haematology

    Volume 174, Issue 3, August 2016, Pages: 444–453, Hyunsoo Cho, Jong Hee Chang, Yu Ri Kim, Soo-Jeong Kim, Haerim Chung, Hyunsung Park, Jung Yeon Lee, Ji Eun Jang, Yundeok Kim, Se Hoon Kim, Woo Ick Yang, Chang-Ok Suh, June-Won Cheong, Yoo Hong Min and Jin Seok Kim

    Version of Record online : 28 MAR 2016, DOI: 10.1111/bjh.14069

  8. You have free access to this content
    Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era

    British Journal of Haematology

    Volume 160, Issue 5, March 2013, Pages: 608–617, Philippe Armand, Sarah Welch, Haesook T. Kim, Ann S. LaCasce, Eric D. Jacobsen, Matthew S. Davids, Caron Jacobson, David C. Fisher, Jennifer R. Brown, Erin Coughlin, Arnold S. Freedman and Yi-Bin Chen

    Version of Record online : 29 DEC 2012, DOI: 10.1111/bjh.12176

  9. You have free access to this content
    Guidelines on transfusion for fetuses, neonates and older children

    British Journal of Haematology

    Volume 175, Issue 5, December 2016, Pages: 784–828, Helen V. New, Jennifer Berryman, Paula H. B. Bolton-Maggs, Carol Cantwell, Elizabeth A. Chalmers, Tony Davies, Ruth Gottstein, Andrea Kelleher, Sailesh Kumar, Sarah L. Morley, Simon J. Stanworth and on behalf of the British Committee for Standards in Haematology

    Version of Record online : 11 NOV 2016, DOI: 10.1111/bjh.14233

  10. You have free access to this content
    Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 327–336, Emilia Pardal, Mónica Coronado, Alejandro Martín, Carlos Grande, Ana Marín-Niebla, Carlos Panizo, José Luis Bello, Eulogio Conde, Miguel T. Hernández, Reyes Arranz, Joan Bargay, Eva González-Barca, Elena Pérez-Ceballos, Santiago Montes-Moreno and María Dolores Caballero

    Version of Record online : 28 JUL 2014, DOI: 10.1111/bjh.13036

  11. You have free access to this content
    Guideline for the diagnosis and management of the rare coagulation disorders

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 304–326, Andrew D. Mumford, Sam Ackroyd, Raza Alikhan, Louise Bowles, Pratima Chowdary, John Grainger, Jason Mainwaring, Mary Mathias, Niamh O'Connell and on behalf of the BCSH Committee

    Version of Record online : 6 AUG 2014, DOI: 10.1111/bjh.13058

  12. You have free access to this content
    Current status of prognostication in classical Hodgkin lymphoma

    British Journal of Haematology

    Volume 165, Issue 3, May 2014, Pages: 287–299, Girish Venkataraman, M. Kamran Mirza, Dennis A. Eichenauer and Volker Diehl

    Version of Record online : 4 FEB 2014, DOI: 10.1111/bjh.12759

  13. You have free access to this content
    Second autologous transplant as salvage therapy in multiple myeloma

    British Journal of Haematology

    Volume 163, Issue 5, December 2013, Pages: 565–572, Djordje Atanackovic and Georgia Schilling

    Version of Record online : 23 SEP 2013, DOI: 10.1111/bjh.12579

  14. You have free access to this content
    Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma

    British Journal of Haematology

    Volume 160, Issue 2, January 2013, Pages: 207–215, Gaetano Corazzelli, Francesco Angrilli, Alfonso D'Arco, Felicetto Ferrara, Pellegrino Musto, Attilio Guarini, Maria Christina Cox, Caterina Stelitano, Sergio Storti, Emilio Iannitto, Simona Falorio, Catello Califano, Alfonso Amore, Manuela Arcamone, Rosaria De Filippi and Antonio Pinto

    Version of Record online : 20 NOV 2012, DOI: 10.1111/bjh.12120

  15. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group

    British Journal of Haematology

    Volume 169, Issue 2, April 2015, Pages: 188–198, Noelia Purroy, Juan Bergua, Laura Gallur, Julio Prieto, Luis A. Lopez, Juan M. Sancho, Jose A. García-Marco, Josep Castellví, Santiago Montes-Moreno, Ana Batlle, Sonia Gonzalez de Villambrosia, Fernando Carnicero, Lucía Ferrando-Lamana, Miguel A Piris and Andrés Lopez

    Version of Record online : 18 DEC 2014, DOI: 10.1111/bjh.13273

  16. You have free access to this content
    Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies

    British Journal of Haematology

    Volume 166, Issue 3, August 2014, Pages: 336–351, Toby A. Eyre, Graham P. Collins, Anthony H. Goldstone and Kate Cwynarski

    Version of Record online : 19 MAY 2014, DOI: 10.1111/bjh.12945

  17. Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy

    British Journal of Haematology

    Volume 174, Issue 6, September 2016, Pages: 859–867, Carmen Martínez, Antonio Díaz-López, Mercedes Rodriguez-Calvillo, Ramón García-Sanz, María José Terol, Elena Pérez-Ceballos, Maria J. Jiménez, Alberto Cantalapiedra, Eva Domingo-Domenech, María José Rodriguez, Antonia Sampol, Manuel Espeso, Francisco-Javier López, Javier Briones, Juan F. García, Anna Sureda and on behalf of Hodgkin Lymphoma Subcommittee of Spanish Group of Lymphoma Bone Marrow Transplantation(GELTAMO)

    Version of Record online : 17 MAY 2016, DOI: 10.1111/bjh.14133

  18. Recent advances in the management of AL Amyloidosis

    British Journal of Haematology

    Volume 172, Issue 2, January 2016, Pages: 170–186, Efstathios Kastritis and Meletios A. Dimopoulos

    Version of Record online : 22 OCT 2015, DOI: 10.1111/bjh.13805

  19. Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma

    British Journal of Haematology

    Volume 173, Issue 4, May 2016, Pages: 597–616, Matthew J. Barth, Yaya Chu, Patrick J. Hanley and Mitchell S. Cairo

    Version of Record online : 7 APR 2016, DOI: 10.1111/bjh.14078

  20. A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma

    British Journal of Haematology

    Volume 173, Issue 3, May 2016, Pages: 432–443, Knut B. Smeland, Cecilie E. Kiserud, Grete F. Lauritzsen, Anne K. Blystad, Unn-Merete Fagerli, Ragnhild S. Falk, Øystein Fluge, Alexander Fosså, Arne Kolstad, Jon H. Loge, Martin Maisenhölder, Bjørn Østenstad, Stein Kvaløy and Harald Holte

    Version of Record online : 23 FEB 2016, DOI: 10.1111/bjh.13965